Anti-Helicobacter pylori potential of artemisinin and its derivatives

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 9, 2012, Pages 4594-4607

  Goswami, Suchandra ^a   Bhakuni, Rajendra S ^b   Chinniah, Annalakshmi ^a   Pal, Anirban ^b   Kar, Sudip K ^a   Das, Pratap K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANHYDRODIHYDROARTEMISININ; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ARTECYCLOPENTANYLMETHER; ARTECYCLOPROPYLMETHER DERIVATIVE; ARTEFURFURYLETHER; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTEPIPERNOYLETHER; BETA ARTECYCLOPROPYLMETHER; CLARITHROMYCIN; DIHYDROARTEMISININYL 3,4,5 TRI O METHYLGALLATE; DIHYDROARTEMISININYL 4 CHLOROBENZOATE; METRONIDAZOLE; OMEPRAZOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL STRUCTURE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG SYNTHESIS; FEMALE; FUNGAL STRAIN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH PH;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMALARIALS; ARTEMISIA ANNUA; ARTEMISININS; CELL LINE, TUMOR; CELL SURVIVAL; CLARITHROMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PLANT COMPONENTS, AERIAL;

EID: 84865441391     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00407-12     Document Type: Article

References (49)

1. Andersen LP. 2007. Colonization and infection by Helicobacter pylori in humans. Helicobacter 12(Suppl 2):12-15. (Pubitemid 350076230)
2. Bauer AW, Kirby WM, Sherris JC, Turck M. 1966. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496.
3. Bhakuni RS, Jain DC, Sharma RP. 1995. An improved procedure for the synthesis of ether of dihydroartemisinin. Ind. J. Chem. 34B:529-530.
4. Bhakuni RS, et al. January 2004. Single pot conversion of artemisinin into artemether. U.S. patent 6,683,193, MY-129031-A(2007).
5. Chaijaroenkul W, Viyanant V, Mahavorasirikul W, Na-Bangchang K. 2011. Cytotoxic activity of artemisinin derivatives against cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines. Asian Pac. J. Cancer Prev. 12:55-59.
6. Cherian S, Forbes D, Sanfilippo F, Cook A, Burgner D. 2008. The epidemiology of Helicobacter pylori infection in African refugee children resettled in Australia. Med. J. Aust. 189:438-441.
7. Datta S, et al. 2005. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment. Pharmacol. Ther. 22:51-57. (Pubitemid 40943875)
8. Erah PO, Goddard AF, Barrett DA, Shaw PN, Spiller RC. 1997. The stability of amoxicillin, clarithromycin, and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J. Antimicrob. Chemother. 39:5-12. (Pubitemid 27092263)
9. Fahey TJ, et al. 1992. Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148:2764-2769.
10. Funatogawa K, et al. 2004. Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori. Microbiol. Immunol. 48:251-261. (Pubitemid 38508665)
11. Glupczynski Y. 1996. Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing, p 17-28. In Lee A, Megraud F (ed), Helicobacter pylori: techniques for clinical diagnosis and basic research. WB Saunders Co, Ltd, London, England.
12. Graham DY, Qureshi WA. 2000. Antibiotic-resistant Helicobacter pylori infection and its treatment. Curr. Pharm. Des. 6:1537-1544.
13. Hachem CY, et al. 1996. Antimicrobial susceptibility testing of Helicobacter pylori: comparison of E-test, broth microdilution, and disc diffusion for ampicillin, clarithromycin, and metronidazole. Diagn. Microbiol. Infect. Dis. 24:37-41. (Pubitemid 26116265)
14. Hagemann T, et al. 2008. "Re-educating" tumor-associated macrophages by targeting NF-B. J. Exp. Med. 205:1261-1268. (Pubitemid 351831483)
15. Haynes RK, et al. 2002. C-10 ester and ether derivatives of dihydroartemisinin-10-α artesunate, preparation of authentic 10-β artesunate, and of other ester and ether derivatives bearing potential aromatic intercalating groups at C-10. Eur. J. Org. Chem. 2002:113-132.
16. Hou TJ, Xia K, Zhang W, Xu XJ. 2004. ADME evaluation in drug discovery. 4. prediction of aqueous solubility based on atom contribution approach. J. Chem. Infect. Comput. Sci. 44:266-275.
17. Iwao E, Yamamoto K, Yokoyama Y, Hirayama F, Haga K. 2004. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori. J. Infect. Chemother. 10:90-96. (Pubitemid 38590731)
18. Jain DC, et al. September 1999. Process for the simultaneous production of artemisinin and essential oil from plant Artemisia annua. U.S. patent 5,955,084.
19. Jayaraman KS. 2003. Technology, tradition unite in India's drug discovery scheme. Nat. Med. 9:982. (Pubitemid 37021766)
20. Jung M, Lee K, Kim H, Park M. 2004. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents. Curr. Med. Chem. 11:1265-1284. (Pubitemid 38585066)
21. Jung M, Lee S. 1998. Stability of acetal and non-acetal-type analogs of artemisinin in simulated stomach acid. Bioorg. Med. Chem. Lett. 8:1003-1006. (Pubitemid 28216273)
22. Kanamaru T, et al. 2001. In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection. Antimicrob. Agents Chemother. 45:2455-2459. (Pubitemid 32801895)
23. Kawase M, Motohashi N. 2004. Plant-derived leading compound for eradication of Helicobacter pylori. Curr. Med. Chem. 3:89-100. (Pubitemid 38854993)
24. Koga T, et al. 2002. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo. J. Antimicrob. Chemother. 50:133-136. (Pubitemid 34785268)
25. Kuhn T, Wang Y. 2008. Artemisinin: an innovative cornerstone for antimalaria therapy. Prog. Drug Res. 383:385-422.
26. Kwon DH, et al. 2000. Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob. Agents Chemother. 44:3203-3205.
27. Li J, Zhou B. 2010. Biological actions of artemisinin: insights from medicinal chemistry studies. Molecules 15:1378-1397.
28. Lin YT, Kwon YI, Labbe RG, Shetty K. 2005. Inhibition of Helicobacter pylori and associated urease by oregano and cranberry phytochemical synergies. Appl. Environ. Microbiol. 71:8558-8564. (Pubitemid 41803988)
29. Malfertheiner P, et al. 2005. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am. J. Gastroenterol. 100:2100-2115.
30. Marshall BJ. 2001. One hundred years of discovery and rediscovery of Helicobacter pylori and its association with peptic ulcer disease, p 19-24. In Mobley HLT, Mendz GL, Hazell SL (ed), Helicobacter pylori: physiology and genetics. ASM Press, Washington, DC.
31. McNulty C, et al. 2002. Helicobacter pylori susceptibility testing by disc diffusion. J. Antimicrob. Chemother. 49:601-609. (Pubitemid 34428974)
32. Megraud F. 2004. Basis for the management of drug-resistant Helicobacter pylori infection. Drugs 64:1893-1904. (Pubitemid 39243570)
33. Megraud F, Lehn N, Lind T. 1997. The MACH 2 Study: Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome. Gastroenterology 112:A216.
34. Mendonça S, et al. 2000. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 5:79-83. (Pubitemid 34951164)
35. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63. (Pubitemid 14203433)
36. Nostro A, et al. 2005. Antibacterial effect of plant extracts against Helicobacter pylori. Phytother. Res. 19:198-202. (Pubitemid 40827641)
37. O'Neill PM, et al. 2001. Optimization of the allylsilane approach to C-10 deoxo-carba analogues of dihydroartemisinin: synthesis and in vitro antimalarial activity of new, metabolically stable C-10 analogues. J. Chem. Soc. Perkin Trans. 1:2682-2689. (Pubitemid 35297604)
38. O'Rourke J, Bode G. 2001. Morphology and ultrastructure, p 53-67. In Mobley HLT, Mendz GL, Hazell SL (ed), Helicobacter pylori: physiology and genetics. ASM Press, Washington, DC.
39. Potasman I, Yitzhak A. 1998. Helicobacter pylori serostatus in backpackers following travel to tropical countries. Am. J. Trop. Med. Hyg. 58:305-308. (Pubitemid 28160749)
40. Posner GH, et al. 1999. Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. J. Med. Chem. 42:4275-4280. (Pubitemid 29504131)
41. Schuster BG. 2001. Demonstrating the validity of natural products as anti-infective drugs. J. Altern. Complement. Med. 7(Suppl 1):73-82.
42. Shrimali M, Bhattacharya AK, Bhakuni RS, Jain DC, Sharma RP. 2001. A process for the preparation of sodium artelinate. Indian patent 185198.
43. Simon JE, Chadwick AF, Craker LE. 1984. Herbs: an indexed bibliography, p 1971-1980. In The scientific literature on selected herbs and aromatic and medicinal plants of the temperate zone. Archon Books, Hamden, CT.
44. Singh BL, et al. 2001. Simultaneous determination of antimalarial artemisinin, dihydroartemisinin and arteether using reversed phase high performance liquid chromatography. J. Ind. Chem. Soc. 78:489-491. (Pubitemid 34016080)
45. Tawfik AF, Bishop SJ, Ayalp A, el-Feraly FS. 1990. Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice. Int. J. Immunopharmacol. 12:385-389. (Pubitemid 20203629)
46. van Zanten SJOV, Kolesnikow T, Leung V, O'Rourke JL, Lee A. 2003. Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model. Antimicrob. Agents Chemother. 47:2249-2255.
47. Wang J, Guo Y, Zhang BC, Chen ZT, Gao JF. 2007. Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydortemisinin in murine lymphatic endothelial cells. Pharmacology 80:207-218. (Pubitemid 47557254)
48. Williamson JS. 2001. Helicobacter pylori: current chemotherapy and new targets for drug design. Curr. Pharm. Des. 7:355-392. (Pubitemid 32409726)
49. Yanagawa Y, Yamamoto Y, Hara Y, Shimamura T. 2003. A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro. Curr. Microbiol. 47:244-249. (Pubitemid 36993301)